National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

menogaril
A semisynthetic derivative of the anthracycline antineoplastic antibiotic nogalamycin. Menogaril intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. This agent is less cardiotoxic than doxorubicin. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Menogarol
Abbreviations:7-OMEN
MEN
TUT-7
Code name:U-52047
Chemical structure names:
  • [2R-(2alpha,3beta,4alpha,5beta,6alpha,11alpha,13alpha)]-4-(dimethylamino)-3,4,5,6,11,12,13,14-octahydro-3,5,8,10,13-pentahydroxy-11-methoxy-6,13-dimethyl-2,6-epoxy-2H-naphthaceno[1,2-b]oxocin-9,16-dione
  • 7-(R)-O-methylnogarol
  • 7-con-O-methylnogarol
  • 7-con-O-methylnorgarol



Previous:melanoma helper peptide vaccine, meloxicam, melphalan, memantine hydrochloride, menatetrenone
Next:Menogarol, meperidine hydrochloride, Meprolone, mercaptopurine, Mercaptopurinum

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov